Volume : 09, Issue : 04, April – 2022
Title:
33.ANXIETY AND DEPRESSION AMONG TYPE 2 DIABETICS VISITING PRIMARY HEALTH CARE CENTER AT ARMED FORCES HOSPITAL IN DHAHRAN, SAUDI ARABIA: PREVALENCE AND ASSOCIATED FACTORS
Authors :
Saif Altalhi*, Mohammed AlQarni, Abdullah AlEnzi, Hanouf AlHusayni
Abstract :
Objectives: The objectives of the study were to assess the prevalence of anxiety and depression among type 2 diabetes mellitus (T2DM) patients and to identify the associated risk factors of anxiety and depression among T2DM patients.
Method: This cross-sectional study was conducted between September and November 2021 in a primary health care center (PHCC) at armed forces hospital in Dhahran, Eastern region of Saudi Arabia. Calculated sample size was 341 Saudi nationals T2DM patients aging between 18 to 40 years. Hospital anxiety and depression scale (HADS) was used to assess the prevalence of anxiety and depression among study participants.
Results: Prevalence of anxiety was found among 76(22.6%) and depression in 40(11.9%) of the study participants. Significantly high proportion of female patients were suffering from anxiety (p=0.007) and depression (0.003). Marital status and presence of comorbidities were also found significant association with prevalence of anxiety and depression. Management of diabetes through diet and exercise or taking oral medicine reduced the chances of anxiety (p=0.00 and p=0.00) and depression (p=0.001 and p=0.015).
Conclusion: The study has shown that the prevalence of anxiety among T2DM was found higher than depression. Several factors were found significant cause of developing anxiety and depression namely, gender, marital status, occupation, comorbidities and diabetes management.
Keywords: T2DM, Anxiety, Depression, Primary health care, Prevalence
Cite This Article:
Please cite this article in press Saif Altalhi et al, Anxiety And Depression Among Type 2 Diabetics Visiting Primary Health Care Center At Armed Forces Hospital In Dhahran, Saudi Arabia: Prevalence And Associated Factors., Indo Am. J. P. Sci, 2022; 09(04).,
Number of Downloads : 10
References:
1. WHO. Global report on diabetes executive summary Internet]. Available: http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf
2. International Diabetes Federation. Diabetes Atlas , 4 [http://www.worlddiabetesfoundation.org/composite-35.htm], Accessed October 20th, 2019
3. Al-Hariri M, Khan S, Albaker W, Al Malik W. Impact of Knowledge and Practice on Fasting Blood Glucose Levels among Diabetics During Ramadan Fasting. Journal of epidemiology and global health. 2019 Dec;9(4):288.
4. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103;137–49.
5. Holt RIG, Mitchell AJ. Diabetes mellitus and severe mental illness: mechanisms and clinical implications. Nat Publ Gr [Internet] 2014; 11(2): 79e89. Nature Publishing Group. Available from: http://dx.doi.org/10.1038/nrendo.2014.203
6. Medved V. The comorbidity of diabetes mellitus. Psychiatria Danubina 2009; 21(4): 585e588.
7. Huang CJ, Lin CH, Lee MH, Chang KP, Chiu HC. Prevalence and incidence of diagnosed depression disorders in patients with diabetes: a national population-based cohort study. Gen Hosp Psychiatry. 2012;34:242-8.
8. Huang CJ, Chiu HC, Lee MH, Wang SY. Prevalence and incidence of anxiety disorders in diabetic patients: a national population-based cohort study. Gen Hosp Psychiatry. 2011;33:8-15.
9. Alduraywish A, Fattah DA, Abd-eltawab A, Al-ruwili M, Alhassan A, Alnafe N, et al. Depression and anxiety and their correlates in patients with diabetes mellitus in Al-Jouf Region, Saudi Arabia. Clin Med Diagn. 2017;7(2):48–56. 26.
10. Al-Mohaimeed AA. Prevalence and factors associated with anxiety and depression among type 2 diabetes in Qassim: a descriptive crosssectional study. J Taibah Univ Med Sci. 2017;12(5):430–6. https://doi. Org/10.1016/j.jtumed.2017.04.002.
11. Hellman R. The Patient Safety Exchange. AACE Patient Safety – Editorials. Depression and Diabetes and Patient Safety. Editorial dated 09-02;2008:16:42:38.
12. Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008;31:420-6.
13. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007;29:147-55
14. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosom Med 2001;63:619-30.
15. Alzahrani A, Alghamdi A, Alqarni T, Alshareef R, Alzahrani A. Prevalence and predictors of depression, anxiety, and stress symptoms among patients with type II diabetes attending primary healthcare centers in the western region of Saudi Arabia: a cross-sectional study. Int J Ment Health Syst. 2019 Jul 16;13:48. doi: 10.1186/s13033-019-0307-6. PMID: 31341512; PMCID: PMC6631923.
16. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand [Internet] 1983 Jun; 67(6): 361e370 [cited 2017 Jan 19]. Available from: http://www.ncbi.nlm.nih. Gov/pubmed/6880820.
17. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. J Psychosom Res [Internet] 2002; 52: 69e77. Available from: http://www. sciencedirect.com/science/article/pii/S0022399901002963.
18. Al-Khathami AD, Ogbeide DO. Prevalence of mental illness among Saudi adult primary-care patients in Central Saudi Arabia. Saudi Med J 2002; 23(6): 721e724.
19. El Mahalli AA. Prevalence and predictors of depression among type 2 diabetes mellitus outpatients in Eastern Province, Saudi Arabia. Int J Health Sci (Qassim) [Internet] 2015; 9(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4538888/.
20. Ganasegeran K, Renganathan P, Manaf RA, Al-Dubai SAR. Factors associated with anxiety and depression among type 2 diabetes outpatients in Malaysia: a descriptive cross-sectional single-centre study. BMJ Open [Internet] 2014; 4(4): e004794. Available from: http://www.pubmedcentral.nih.gov/arti clerender.fcgi?artid¼4010817&tool¼pmcentrez&rendertype¼ abstract.
21. Collins MM, Corcoran P, Perry IJ. Psychology anxiety and depression symptoms in patients with diabetes. Diabet Med 2009: 153e161.
22. Sun N, Lou P, Shang Y, Zhang P, Wang J, Chang G, Shi C. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ open. 2016 Aug 1;6(8).
23. Khuwaja AK, Kadir MM: Gender differences and clustering patterns of behavioral risk factors for chronic non-communicable diseases: community-based study from a developing country. Chronic Illn 2010, 6(3):163-170.
24. Al-Tuwijri A, Al-Doghether M, Akturk Z, et al. Quality of life of people with diabetes attending primary care health centres in Riyadh: bad control good quality? Qual Prim Care 2007;15:307–14.
25. Hawamdeh S, Dator WLT, Abunab HY. Prevalence of depression among Arab women with type 2 diabetes: a systematic review and meta-analysis. Health 2016; 650-657.
26. Mikaliū kštienė A, Žagminas K, Juozulynas A, et al. Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania. Med Sci Monit 2014;20:182–90.
27. Huang CJ, Hsieh HM, Tu HP, Jiang HJ, Wang PW, Lin CH. Generalized anxiety disorder in type 2 diabetes mellitus: prevalence and clinical characteristics. Brazilian Journal of Psychiatry. 2020 Dec;42(6):621-9.
28. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat clin Pract Endocrinol Metab. 2009; 5:150-9.